AARDEX Group partners with the Digital Medical Society's new project to improve user needs

Published on May 12, 2023

AARDEX Group has joined forces with other industry companies to partner with a new project from The Digital Medical Society (DiMe) called Extending the Verification, Analytical Validation, and Clinical Validation â or V3+ Framework.

Continue reading on website
Other news

Servier receives European Commission marketing approval for leukemia drug

May 12, 2023
Servier has received marketing approval from the European Commission (EC) for Tibsovo (ivosidenib tablets) to treat isocitrate dehydrogenase-1 (IDH1)-mutated acute myeloid leukaemia (AML) and IDH1-mutated cholangiocarcinoma.

Orgenesis secures $5M investment for point-of-care service subsidiary

May 12, 2023
Orgenesis has secured $5 million from Metalmark Capital Partners to accelerate the growth of its point-of-care (POCare) services subsidiary.